Comparison between Dipna Pharmachem IPO and Shantidoot Infra IPO.
Dipna Pharmachem IPO is a SME Fixed Price IPO proposed to list at BSE SME while Shantidoot Infra IPO is a SME Fixed Price proposed to list at BSE SME.
| Dipna Pharmachem IPO | Shantidoot Infra IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sernet Financial Services Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dipna Pharmachem IPO is up to ₹14.43 Cr whereas the issue size of the Shantidoot Infra IPO is up to ₹3.81 Cr. The final issue price of Dipna Pharmachem IPO is ₹38.00 per share and of Shantidoot Infra IPO is ₹81.00 per share.
| Dipna Pharmachem IPO | Shantidoot Infra IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹38.00 per share | ₹81.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 37,98,000 shares | 2,22,400 shares |
| Fresh Issue Size (Amount) | up to ₹14.43 Cr | up to ₹1.80 Cr |
| OFS Issue Size | 0 shares | 2,48,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹2.01 Cr |
| Issue Size Total | 37,98,000 shares | 4,70,400 shares |
| Issue Size Total (Amount) | up to ₹14.43 Cr | up to ₹3.81 Cr |
Dipna Pharmachem IPO opens on Aug 25, 2022, while Shantidoot Infra IPO opens on Sep 06, 2022. The closing date of Dipna Pharmachem IPO and Shantidoot Infra IPO is Aug 30, 2022, and Sep 09, 2022, respectively.
| Dipna Pharmachem IPO | Shantidoot Infra IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 25, 2022 | Sep 06, 2022 |
| Issue Close | Aug 30, 2022 | Sep 09, 2022 |
| Basis Of Allotment (Tentative) | Sep 14, 2022 | |
| Initiation of Refunds (Tentative) | Sep 15, 2022 | |
| Credit of Share (Tentative) | Sep 16, 2022 | |
| Listing date (Tentative) | Sep 08, 2022 | Sep 19, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dipna Pharmachem IPO P/E ratio is 39, as compared to Shantidoot Infra IPO P/E ratio of 10.37.
| Dipna Pharmachem IPO | Shantidoot Infra IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.56 | 72.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39 | 10.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹45.49 Cr. | ₹14.56 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dipna Pharmachem IPO Retail Individual Investors (RII) are offered 18,99,000 shares while in Shantidoot Infra IPO retail investors are offered 18,99,000 shares. Qualified Institutional Buyers (QIB) are offered in Dipna Pharmachem IPO and in Shantidoot Infra IPO.
| Dipna Pharmachem IPO | Shantidoot Infra IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 2,04,000 shares | 25,600 shares |
| QIB | ||
| NII | 18,99,000 shares | 2,35,200 shares |
| RII | 18,99,000 shares | 2,35,200 shares |
| Employee | ||
| Others | ||
| Total | 37,98,000 shares | 4,70,400 shares |
Dipna Pharmachem IPO subscribed 2.77x in total, whereas Shantidoot Infra IPO subscribed 2.85x.
| Dipna Pharmachem IPO | Shantidoot Infra IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.78x | 2.36x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.75x | 3.33x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.77x | 2.85x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
